Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Joint Disorders Under Anastrozole in Early Breast Cancer
NCT00323479Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2006
- Primary completion
- Jan 2009
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of anastrozole in breast cancer, sponsored by AstraZeneca. Started Jun 2006; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00323479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323479.